﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.1" xsi:schemaLocation="http://www.irs.gov/efile">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-10-22T09:36:07-07:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>010583969</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PISANI CPA LLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>874 BROADWAY</AddressLine1Txt>
        <CityNm>BRENTWOOD</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>11717</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>131623998</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>The Eye-Bank for Sight Restoration Inc</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>DBA The Eye-Bank of New York</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>EYE-</BusinessNameControlTxt>
      <PhoneNum>2127429000</PhoneNum>
      <USAddress>
        <AddressLine1Txt>120 Wall Street 3rd Floor</AddressLine1Txt>
        <CityNm>New York</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10005</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>Dennis R Tarzian</PersonNm>
      <PersonTitleTxt>President</PersonTitleTxt>
      <SignatureDt>2024-10-22</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>Sara Pisani</PreparerPersonNm>
      <PTIN>P12345678</PTIN>
      <PhoneNum>6318042533</PhoneNum>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="IRS990" referenceDocumentId="IRS990ScheduleO" softwareId="23017517" softwareVersionNum="2023v5.1">
      <PrincipalOfficerNm>Dennis R Tarzian</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>120 Wall Street 3rd Floor</AddressLine1Txt>
        <CityNm>New York</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10005</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>20441807</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>www.eyedonation.org</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1944</FormationYr>
      <LegalDomicileStateCd>NY</LegalDomicileStateCd>
      <ActivityOrMissionDesc>The Eye-Bank's mission is to restore sight through eye donations and cornea transplants.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>20</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>20</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>66</TotalEmployeeCnt>
      <TotalVolunteersCnt>32</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>586085</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>612722</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>5203115</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>5637404</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>7679150</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>5404617</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>2516</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>10615</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>13470866</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>11665358</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>10023</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>20842</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>5356949</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>5452446</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>789627</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>4722411</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>4340173</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>10089383</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>9813461</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>3381483</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>1851897</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>70258852</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>81420040</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>3539748</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>2934031</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>66719104</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>78486009</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>The Eye-Bank for Sight Restoration (The Eye-Bank), the worlds first eye bank, is devoted to restoring sight through eye donations and cornea transplants, as well as providing ocular tissue for research into treatment and cures for other eye diseases. Public awareness about the need for eye donations is a key component of our efforts to restore sight to more than a thousand of individuals each year.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>4708108</ExpenseAmt>
      <GrantAmt>14842</GrantAmt>
      <RevenueAmt>5666618</RevenueAmt>
      <Desc>The Eye-Banks state-of-the-art ocular laboratory operates 24/7 to recover, evaluate and distribute safe, quality donor eye tissue for cornea transplants and other ophthalmic surgeries. Staff receives continual education and training in the latest technological advances, including preparing partial thickness grafts for endothelial keratoplasty (EK) procedures.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>870819</ExpenseAmt>
        <Desc>The Eye-Banks Ocular Tissue Research Program supplies donor eye tissue to medical scientists researching cures and treatment of eye diseases such as cataracts, glaucoma and diseases of the retina. The Eye-Bank also provides adult human Retina Pigment Epithelial (ah-RPE) cells to a growing number of researchers across the country who are conducting studies on the potential for transplanting RPE cells in the future. The Eye-Bank distributed 121% more donor tissue to researchers in 2023 (190 tissues) over 2022 (86 tissues). This significant increase is due in part to The Eye-Banks addition of a Research and Relationship Development Manager position as well as our hosting a reception at the 2023 meeting of ARVO (Association for Research in Vision and Ophthalmology) which enabled us to meet in-person with researchers currently using our donor tissue and cultivate new opportunities for our Research Program to collaborate.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>724950</ExpenseAmt>
        <Desc>The Eye-Banks Public Education Program offers resources and materials about eye donation to the general public including brochures and a newsletter, eye-to-eye, which is circulated to more than 20,000 transplant recipients, friends and supporters of The Eye-Bank and an effective website that also offers valuable information in Spanish as well as English about eye donation and cornea transplantation; how to write to your donor family; and how to enroll in the NYS Donate Life Registry.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalOtherProgSrvcExpenseAmt>1444965</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcGrantAmt>6000</TotalOtherProgSrvcGrantAmt>
      <TotalProgramServiceExpensesAmt>7748842</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="IRS990ScheduleD">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="IRS990ScheduleD">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="IRS990ScheduleD">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="IRS990ScheduleD">true</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="IRSScheduleD">true</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="IRS990ScheduleD">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="IRS990ScheduleG">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="IRS990ScheduleG">false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="IRS990ScheduleJ">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="IRS990ScheduleM">true</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="IRS990ScheduleM">false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>28</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>66</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>true</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>true</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <Form8282FiledCnt>0</Form8282FiledCnt>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>20</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>20</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>FL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>Patricia Dahl</PersonNm>
        <PhoneNum>2127429000</PhoneNum>
        <USAddress>
          <AddressLine1Txt>120 Wall St 3rd Fl</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10005</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>Patricia Dahl</PersonNm>
        <TitleTxt>CEO/Exec. Dir.</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>311000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>47545</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Edwin Roberts</PersonNm>
        <TitleTxt>Associate Director</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <ReportableCompFromOrgAmt>177796</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>56326</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Karen Bardavid</PersonNm>
        <TitleTxt>Dir of Development</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <ReportableCompFromOrgAmt>165448</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>55066</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Hortense Kendall</PersonNm>
        <TitleTxt>Laboratory Manager</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <ReportableCompFromOrgAmt>144194</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>51121</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Noel Mick Moschetta</PersonNm>
        <TitleTxt>Dir Communications</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <ReportableCompFromOrgAmt>159115</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>31964</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Dana Arifi</PersonNm>
        <TitleTxt>Dir Fin &amp; Admin</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <ReportableCompFromOrgAmt>140850</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>30024</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Courtney DiTullio</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Manish Krishnan</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Rachel A Heisler</PersonNm>
        <TitleTxt>Secretary</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Umber Ahmad</PersonNm>
        <TitleTxt>Treasurer</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Joan Larson</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Jeanne McCooey</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Giovanni F DiCenso</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Leo J Corbett</PersonNm>
        <TitleTxt>President</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Audrey MacIsaac</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Paul Kayaian</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Dennis R Tarzian</PersonNm>
        <TitleTxt>Vice President</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Richard A Mittenthal</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Joseph J D'Ambrosio</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Andrea Nordquist</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>David R Adler</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Michele A Masucci</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Rocio Sanz</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Michael Zambrelli</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Joseph J Shaheen</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Sruthi Madhavan</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>1098403</TotalReportableCompFromOrgAmt>
      <TotalOtherCompensationAmt>272046</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>13</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>Power Media Inc</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>380 N Broadway Suite 204</AddressLine1Txt>
            <CityNm>Jericho</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11753</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>Marketing</ServicesDesc>
        <CompensationAmt>463570</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>Pisani CPA LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>874 Broadway</AddressLine1Txt>
            <CityNm>Brentwood</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11717</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>Accounting</ServicesDesc>
        <CompensationAmt>112504</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>2</CntrctRcvdGreaterThan100KCnt>
      <FundraisingAmt>130561</FundraisingAmt>
      <AllOtherContributionsAmt>482161</AllOtherContributionsAmt>
      <NoncashContributionsAmt>44350</NoncashContributionsAmt>
      <TotalContributionsAmt>612722</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>Processing fees</Desc>
        <BusinessCd>621500</BusinessCd>
        <TotalRevenueColumnAmt>5637404</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5637404</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>5637404</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>1084451</TotalRevenueColumnAmt>
        <ExclusionAmt>1084451</ExclusionAmt>
      </InvestmentIncomeGrp>
      <IncmFromInvestBondProceedsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </IncmFromInvestBondProceedsGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </RoyaltiesRevenueGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>13001873</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>8681707</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>4320166</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>4320166</TotalRevenueColumnAmt>
        <ExclusionAmt>4320166</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>76143</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>130561</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>94742</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>-18599</TotalRevenueColumnAmt>
        <ExclusionAmt>-18599</ExclusionAmt>
      </NetIncmFromFundraisingEvtGrp>
      <NetIncomeFromGamingGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeFromGamingGrp>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>Miscellaneous</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>29214</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>29214</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>29214</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>11665358</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5666618</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>5386018</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>4842</TotalAmt>
        <ProgramServicesAmt>4842</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>16000</TotalAmt>
        <ProgramServicesAmt>16000</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>0</TotalAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>358545</TotalAmt>
        <ProgramServicesAmt>250982</ProgramServicesAmt>
        <ManagementAndGeneralAmt>53780</ManagementAndGeneralAmt>
        <FundraisingAmt>53783</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>0</TotalAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>3783017</TotalAmt>
        <ProgramServicesAmt>2960700</ProgramServicesAmt>
        <ManagementAndGeneralAmt>413621</ManagementAndGeneralAmt>
        <FundraisingAmt>408696</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>268148</TotalAmt>
        <ProgramServicesAmt>191984</ProgramServicesAmt>
        <ManagementAndGeneralAmt>38922</ManagementAndGeneralAmt>
        <FundraisingAmt>37242</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>753582</TotalAmt>
        <ProgramServicesAmt>609028</ProgramServicesAmt>
        <ManagementAndGeneralAmt>56555</ManagementAndGeneralAmt>
        <FundraisingAmt>87999</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>289154</TotalAmt>
        <ProgramServicesAmt>228767</ProgramServicesAmt>
        <ManagementAndGeneralAmt>28974</ManagementAndGeneralAmt>
        <FundraisingAmt>31413</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>28470</TotalAmt>
        <ProgramServicesAmt>27638</ProgramServicesAmt>
        <ManagementAndGeneralAmt>832</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>147882</TotalAmt>
        <ManagementAndGeneralAmt>147882</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>212106</TotalAmt>
        <ManagementAndGeneralAmt>212106</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>195438</TotalAmt>
        <ProgramServicesAmt>195438</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>0</TotalAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>306109</TotalAmt>
        <ProgramServicesAmt>227274</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8322</ManagementAndGeneralAmt>
        <FundraisingAmt>70513</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>0</TotalAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>408724</TotalAmt>
        <ProgramServicesAmt>321079</ProgramServicesAmt>
        <ManagementAndGeneralAmt>48585</ManagementAndGeneralAmt>
        <FundraisingAmt>39060</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>0</TotalAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>58297</TotalAmt>
        <ProgramServicesAmt>36030</ProgramServicesAmt>
        <ManagementAndGeneralAmt>18991</ManagementAndGeneralAmt>
        <FundraisingAmt>3276</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>0</TotalAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>199996</TotalAmt>
        <ProgramServicesAmt>168225</ProgramServicesAmt>
        <ManagementAndGeneralAmt>16731</ManagementAndGeneralAmt>
        <FundraisingAmt>15040</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>102489</TotalAmt>
        <ProgramServicesAmt>68692</ProgramServicesAmt>
        <ManagementAndGeneralAmt>33620</ManagementAndGeneralAmt>
        <FundraisingAmt>177</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>Corneal imports</Desc>
        <TotalAmt>1273285</TotalAmt>
        <ProgramServicesAmt>1273285</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Program marketing</Desc>
        <TotalAmt>464570</TotalAmt>
        <ProgramServicesAmt>464570</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Lab supplies</Desc>
        <TotalAmt>382368</TotalAmt>
        <ProgramServicesAmt>382368</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Other</Desc>
        <TotalAmt>208637</TotalAmt>
        <ProgramServicesAmt>96507</ProgramServicesAmt>
        <ManagementAndGeneralAmt>96467</ManagementAndGeneralAmt>
        <FundraisingAmt>15663</FundraisingAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>351802</TotalAmt>
        <ProgramServicesAmt>225433</ProgramServicesAmt>
        <ManagementAndGeneralAmt>99604</ManagementAndGeneralAmt>
        <FundraisingAmt>26765</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>9813461</TotalAmt>
        <ProgramServicesAmt>7748842</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1274992</ManagementAndGeneralAmt>
        <FundraisingAmt>789627</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <JointCostsInd>X</JointCostsInd>
      <TotalJointCostsGrp>
        <TotalAmt>71524</TotalAmt>
        <ProgramServicesAmt>35762</ProgramServicesAmt>
        <FundraisingAmt>35762</FundraisingAmt>
      </TotalJointCostsGrp>
      <CashNonInterestBearingGrp>
        <EOYAmt>144217</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>1137688</BOYAmt>
        <EOYAmt>330169</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>14107</BOYAmt>
        <EOYAmt>5620</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>1779624</BOYAmt>
        <EOYAmt>1963276</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <OthNotesLoansReceivableNetGrp>
        <EOYAmt>0</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <EOYAmt>0</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>188707</BOYAmt>
        <EOYAmt>230389</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>2845511</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>1949348</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>1058012</BOYAmt>
        <EOYAmt>896163</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>59411356</BOYAmt>
        <EOYAmt>70418075</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <EOYAmt>0</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <EOYAmt>0</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <IntangibleAssetsGrp>
        <EOYAmt>0</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>6669358</BOYAmt>
        <EOYAmt>7432131</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>70258852</BOYAmt>
        <EOYAmt>81420040</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>534895</BOYAmt>
        <EOYAmt>347448</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <EscrowAccountLiabilityGrp>
        <BOYAmt>120062</BOYAmt>
        <EOYAmt>164687</EOYAmt>
      </EscrowAccountLiabilityGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>2884791</BOYAmt>
        <EOYAmt>2421896</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>3539748</BOYAmt>
        <EOYAmt>2934031</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>62484870</BOYAmt>
        <EOYAmt>73850114</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>4234234</BOYAmt>
        <EOYAmt>4635895</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>66719104</BOYAmt>
        <EOYAmt>78486009</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>70258852</BOYAmt>
        <EOYAmt>81420040</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>1851897</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>9511897</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>403111</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA" softwareId="23017517" softwareVersionNum="2023v5.1">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>1223874</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>879540</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>472439</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>586085</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>612722</CurrentTaxYearAmt>
        <TotalAmt>3774660</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TaxRevLeviedOrgnztnlBnft170Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft170Grp>
      <GovtFurnSrvcFcltsVl170Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>1223874</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>879540</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>472439</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>586085</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>612722</CurrentTaxYearAmt>
        <TotalAmt>3774660</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>1539693</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>2234967</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>1081199</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>946096</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>908959</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>847730</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1084451</CurrentTaxYearAmt>
        <TotalAmt>4868435</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <TotalAmt>0</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>32277</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>15178</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>22557</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>7855</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>29214</CurrentTaxYearAmt>
        <TotalAmt>107081</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>8750176</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>20391856</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.25540</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.24590</PublicSupportPY170Pct>
      <TenPctFactsCrcmstncsTestCYInd>X</TenPctFactsCrcmstncsTestCYInd>
      <FactsAndCircumstancesTestTxt>Current Year Facts and Circumstances: THE EYEBANK FOR SIGHT RESTORATION, INC. (THE "EYEBANK") QUALIFIES AS PUBLICLY SUPPORTED BECAUSE IT MEETS THE 10% PLUS FACTS-AND-CIRCUMSTANCES TEST UNDER TREAS REG. 1.170A-9(E)(3) IN THE FOLLOWING RESPECTS:10% OF SUPPORT LIMITATION - AT 25.54% THE EYEBANK'S PUBLIC SUPPORT PERCENTAGE FOR 2023 EXCEEDED 10% AND IS RELATIVELY CLOSE TO 33.3%.PUBLIC BENEFIT: MISSION AND PROGRAMSTHE EYE-BANK FOR SIGHT RESTORATION, THE WORLDS FIRST EYE BANK, IS DEVOTED TO RESTORING SIGHT THROUGH EYE DONATIONS AND CORNEA TRANSPLANTS, AS WELL AS PROVIDING OCULAR TISSUE FOR RESEARCH INTO TREATMENT AND CURES FOR OTHER EYE DISEASES. TO DO THIS, THE EYE-BANK RECOVERS, PROCESSES AND PROVIDES CORNEA TISSUE FOR SIGHT SAVING SURGERIES AND RESEARCH AND INNOVATION. SINCE OUR FOUNDING IN 1944, THE EYE-BANK HAS HELPED PROVIDE THE GIFT OF SIGHT TO MORE THAN 70,000 INDIVIDUALS WHO WOULD OTHERWISE HAVE BEEN BLIND. THE EYE-BANKS MULTI-FACETED AND WELL-ESTABLISHED PROGRAMS INCLUDE A STATE-OF-THE-ART OCULAR LABORATORY WHICH OPERATES 24/7 TO RECOVER, EVALUATE AND DISTRIBUTE SAFE, QUALITY DONOR EYE TISSUE FOR APPROXIMATELY 1,400 CORNEA TRANSPLANTS ANNUALLY AND AN OCULAR TISSUE RESEARCH PROGRAM WHICH SUPPLIES DONOR EYE TISSUE TO MEDICAL SCIENTISTS RESEARCHING CURES AND TREATMENTS OF MULTIPLE EYE DISEASES INCLUDING GLAUCOMA AND DISEASES OF THE RETINA AS WELL AS PROVIDING CULTURED AH-RPE CELLS TO RESEARCHERS STUDYING THE POTENTIAL FOR TRANSPLANTING RPE CELLS. THE PROFESSIONAL EDUCATION PROGRAM PROVIDES INFORMATION ABOUT EYE DONATION AND DONOR CRITERIA TO HEALTH CARE PROFESSIONALS THROUGH IN-SERVICE EDUCATION AT MORE THAN 80 HOSPITALS THROUGHOUT THE EYE-BANKS SERVICE AREA, WHICH INCLUDES NEW YORK CITY, LONG ISLAND AND THE LOWER HUDSON VALLEY, WHILE THE EYE-BANKS PUBLIC EDUCATION PROGRAM OFFERS INFORMATION ABOUT EYE DONATION TO THE GENERAL PUBLIC THROUGH BROCHURES AND A NEWSLETTER, EYE-TO-EYE, WHICH IS CIRCULATED TO MORE THAN 20,000 TRANSPLANT RECIPIENTS, FRIENDS AND SUPPORTERS. A USER-FRIENDLY WEBSITE OFFERS VALUABLE INFORMATION IN SPANISH AS WELL AS ENGLISH ABOUT EYE DONATION AND CORNEA TRANSPLANTATION; HOW TO WRITE TO YOUR DONOR FAMILY; AND HOW TO ENROLL IN THE NYS DONATE LIFE REGISTRY. EVERY DONOR FAMILY IS OFFERED THE NYS DONATE LIFE MEDAL IN HONOR OF THEIR LOVED ONES EYE DONATION. PUBLIC AWARENESS ABOUT THE NEED FOR EYE DONATIONS IS A KEY COMPONENT OF THE EYE-BANKS EFFORTS TO RESTORE SIGHT TO HUNDREDS OF INDIVIDUALS EACH YEAR. THE EYE-BANKS MARKETING PROGRAM INFORMS THE PUBLIC ABOUT THE IMPORTANCE OF EYE DONATION AND ENROLLING IN THE DONATE LIFE REGISTRY THROUGH A MULTI-MEDIA ADVERTISING CAMPAIGN THAT REACHES A NEW YORK METROPOLITAN AUDIENCE VIA RADIO, TELEVISION, NEWSPAPERS, SOCIAL MEDIA AND EMAIL MARKETING INCLUDING SPANISH LANGUAGE OUTLETS. THE YOUNG AMBASSADOR PROGRAM INVITES CORNEA TRANSPLANT RECIPIENTS AGES FOUR TO 17 TO EXPRESS THEMSELVES CREATIVELY THROUGH ART AND POETRY, AND SELECTED EFFORTS ARE FEATURED ON THE EYE-BANKS ANNUAL THANKSGIVING CARD AND ON SOCIAL MEDIA. THIS PROGRAM ALSO AWARDS TWO $3,000 SCHOLARSHIPS ANNUALLY FOR QUALIFYING APPLICANTS PURSUING HIGHER EDUCATION.SOURCES OF SUPPORT: THE EYE-BANK'S FUNDING COMES FROM DIVERSE SOURCES INCLUDING CORPORATIONS AND OTHER ORGANIZATIONS AND INDIVIDUALS. THE ONGOING GOAL IS TO CONTINALLY EXPAND THE EYE-BANKS DONOR BASE.WE PURSUE THIS GOAL BY HOSTING SPECIAL EVENTS INCLUDING SEASONAL BENEFITS EACH ATTENDED BY 275 OR MORE GUESTS AND SPONSORED BY CORPORATE PARTNERS. IN ADDITION TO TICKET SALES, THESE EVENTS INCLUDE A SILENT AUCTION, A LIVE ON-SCREEN JOURNAL AND SPECIAL SOLICITATIONS FOR MAJOR GIFT DONATIONS. IN ADDITION TO PARTNERING WITH MEMBERS OF THE BOARD OF DIRECTORS AND MEDICAL ADVISORY BOARD TO PUBLICIZE THE EYE-BANKS MISSION AND ENCOURAGE FINANCIAL SUPPORT FROM AMONG THEIR OWN CIRCLES, THE EYE-BANK ALSO CREATED A LEADERSHIP COUNCIL. THE PRIMARY PURPOSE OF THE COUNCIL IS TO EXPAND SUPPORT OF THE ORGANIZATIONS ADVOCACY EFFORTS AND ACTIVITIES WITH FUNDRAISING AND NETWORKING EVENTS FOR 50 TO 125 MID-CAREER PROFESSIONALS. THIS SPECIFIC DEMOGRAPHIC, IN COORDINATION WITH A TARGETED SOCIAL MEDIA CAMPAIGNS, MULTIPLIES NEW OPPORTUNITIES FOR PUBLIC AWARENESS AND FUNDRAISING. A CAUSE MARKETING CAMPAIGN WHERE CUSTOMERS WOULD BE ENCOURAGED TO DONATE TO THE EYE-BANK AT A POINT OF SALE OR ONLINE WILL ALSO ENLARGE THE ORGANIZATIONS REACH AND CREATE ADDITIONAL AWARENESS IN ADDITION TO RAISING FUNDS FOR ITS MISSION AS DESCRIBED ABOVE.MULTIPLE SOCIAL MEDIA FUNDRAISING CAMPAIGNS USING FACEBOOK AND STRATEGIC SEARCH ENGINE OPTIMIZATION TARGETS AUDIENCES THAT SUPPORT ORGANIZATIONS WITH A SIMILAR MISSION TO INCREASE USER ENGAGEMENT AND FUNDS RAISED.DIRECT MAIL ACQUISITION CAMPAIGNS REACH A TOTAL OF 98,000 POTENTIAL SUPPORTERS ANNUALLY.REPRESENTATIVE GOVERNING BODY: THE EYEBANK'S ACTIVITIES ARE GOVERNED BY A BOARD OF DIRECTORS REFLECTING A BROAD RANGE OF INDIVIDUALS FROM VARIOUS BACKGROUNDS AND EXPERIENCE. IN ADDITION TO DIVERSE VIEWPOINTS, THEY OFFER SPECIALIZED KNOWLEDGE FOR THE BENEFIT OF THE EYE-BANK, ITS MISSION AND OPERATIONS. Prior Year Facts and Circumstances: THE EYEBANK FOR SIGHT RESTORATION, INC. (THE "EYEBANK") QUALIFIES AS PUBLICLY SUPPORTED BECAUSE IT MEETS THE 10% PLUS FACTS-AND-CIRCUMSTANCES TEST UNDER TREAS REG. 1.170A-9(E)(3) IN THE FOLLOWING RESPECTS:10% OF SUPPORT LIMITATION - AT 24.59% EYEBANKS'S PUBLIC SUPPORT PERCENTAGE FOR 2022 EXCEEDED 10% AND IS RELATIVELY CLOSE TO 33.3%.ATTRACTION OF PUBLIC SUPPORT AND PUBLIC MISSION: THE EYE-BANK FOR SIGHT RESTORATION, THE WORLDS FIRST EYE BANK, IS DEVOTED TO RESTORING SIGHT THROUGH EYE DONATIONS AND CORNEA TRANSPLANTS, AS WELL AS PROVIDING OCULAR TISSUE FOR RESEARCH INTO TREATMENT AND CURES FOR OTHER EYE DISEASES. PUBLIC AWARENESS ABOUT THE NEED FOR EYE DONATIONS IS A KEY COMPONENT OF THE EYE-BANKS EFFORTS TO RESTORE SIGHT TO HUNDREDS OF INDIVIDUALS EACH YEAR. THE EYE-BANKS MULTI-FACETED AND WELL-ESTABLISHED PROGRAMS INCLUDE A STATE-OF-THE-ART OCULAR LABORATORY WHICH OPERATES 24/7 TO RECOVER, EVALUATE AND DISTRIBUTE SAFE, QUALITY DONOR EYE TISSUE FOR APPROXIMATELY 1,400 CORNEA TRANSPLANTS ANNUALLY AND AN OCULAR TISSUE RESEARCH PROGRAM WHICH SUPPLIES DONOR EYE TISSUE TO MEDICAL SCIENTISTS RESEARCHING CURES AND TREATMENTS OF MULTIPLE EYE DISEASES INCLUDING GLAUCOMA AND DISEASES OF THE RETINA AS WELL AS PROVIDING CULTURED AH-RPE CELLS TO RESEARCHERS STUDYING THE POTENTIAL FOR TRANSPLANTING RPE CELLS. THE PROFESSIONAL EDUCATION PROGRAM PROVIDES INFORMATION ABOUT EYE DONATION AND DONOR CRITERIA TO HEALTH CARE PROFESSIONALS THROUGH IN-SERVICE EDUCATION AT MORE THAN 80 HOSPITALS THROUGHOUT THE EYE-BANKS SERVICE AREA, WHICH INCLUDES NEW YORK CITY, LONG ISLAND AND THE LOWER HUDSON VALLEY, WHILE THE EYE-BANKS PUBLIC EDUCATION PROGRAM OFFERS INFORMATION ABOUT EYE DONATION TO THE GENERAL PUBLIC THROUGH BROCHURES AND A NEWSLETTER, EYE-TO-EYE, WHICH IS CIRCULATED TO MORE THAN 20,000 TRANSPLANT RECIPIENTS, FRIENDS AND SUPPORTERS. A USER-FRIENDLY WEBSITE OFFERS VALUABLE INFORMATION IN SPANISH AS WELL AS ENGLISH ABOUT EYE DONATION AND CORNEA TRANSPLANTATION; HOW TO WRITE TO YOUR DONOR FAMILY; AND HOW TO ENROLL IN THE NYS DONATE LIFE REGISTRY. EVERY DONOR FAMILY IS OFFERED THE NYS DONATE LIFE MEDAL IN HONOR OF THEIR LOVED ONES EYE DONATION. THE EYE-BANKS MARKETING PROGRAM INFORMS THE PUBLIC ABOUT THE IMPORTANCE OF EYE DONATION AND ENROLLING IN THE DONATE LIFE REGISTRY THROUGH A MULTI-MEDIA ADVERTISING CAMPAIGN THAT REACHES A NEW YORK METROPOLITAN AUDIENCE VIA RADIO, TELEVISION, NEWSPAPERS, SOCIAL MEDIA AND EMAIL MARKETING INCLUDING SPANISH LANGUAGE OUTLETS. THE YOUNG AMBASSADOR PROGRAM INVITES CORNEA TRANSPLANT RECIPIENTS AGES FOUR TO 17 TO EXPRESS THEMSELVES CREATIVELY THROUGH ART AND POETRY AND SELECTED EFFORTS ARE FEATURED IN THE EYE-BANKS ANNUAL THANKSGIVING CARD AND ON SOCIAL MEDIA. THE PROGRAM ALSO AWARDS TWO $3,000 SCHOLARSHIPS ANNUALLY FOR QUALIFYING APPLICANTS PURSUING HIGHER EDUCATION.SOURCES OF SUPPORT: THE EYE-BANK'S FUNDING COMES FROM DIVERSE SOURCES INCLUDING A NUMBER OF CORPORATIONS, OTHER ORGANIZATIONS AND INDIVIDUALS. IN ORDER TO EXPAND THE POOL OF DONORS THE EYE-BANK PLANS TO: -CONTINUE TO HOST AN INCREASED NUMBER OF SPECIAL EVENTS INCLUDING A FALL AND SPRING BENEFIT AS WELL AS TWO LEADERSHIP COUNCIL CULTIVATION EVENTS, ALL OF WHICH INCLUDE CORPORATE SPONSORSHIP OPPORTUNITIES AND OUTREACH TO NEW AUDIENCES;-PARTNER WITH A MAJOR CORPORATION TO LAUNCH A CAUSE MARKETING CAMPAIGN WHERE CUSTOMERS WOULD BE ENCOURAGED TO DONATE TO THE EYE-BANK AT A POINT OF SALE ;-CREATE AND PROMOTE MULTIPLE SOCIAL MEDIA FUNDRAISING CAMPAIGNS TARGETING AUDIENCES THAT SUPPORT ORGANIZATIONS WITH A SIMILAR MISSION TO THE EYE-BANK;-DOUBLE OUR DIRECT MAIL ACQUISITIONS TO FOUR MAILINGS PER YEAR REACHING A TOTAL OF 98,000 POTENTIAL SUPPORTERS ANNUALLY;-PARTNER WITH OUR BOARD OF DIRECTORS AND MEDICAL ADVISORY BOARD MEMBERS TO CULTIVATE NEW MAJOR DONORS AND ENCOURAGE SUPPORT FROM THEIR BUSINESSES.REPRESENTATIVE GOVERNING BODY: THE EYEBANK'S ACTIVITIES ARE GOVERNED BY A</FactsAndCircumstancesTestTxt>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="23017517" softwareVersionNum="2023v5.1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="IRS990ScheduleD" softwareId="23017517" softwareVersionNum="2023v5.1">
      <AgentTrusteeEtcInd>false</AgentTrusteeEtcInd>
      <InclEscrowCustodialAcctLiabInd>true</InclEscrowCustodialAcctLiabInd>
      <ExplanationProvidedInd>X</ExplanationProvidedInd>
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>64679178</BeginningYearBalanceAmt>
        <ContributionsAmt>20384</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>15090637</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>4450</GrantsOrScholarshipsAmt>
        <OtherExpendituresAmt>4505710</OtherExpendituresAmt>
        <EndYearBalanceAmt>75280039</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>82351106</BeginningYearBalanceAmt>
        <ContributionsAmt>3274</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-13784165</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>3891037</OtherExpendituresAmt>
        <EndYearBalanceAmt>64679178</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>73902547</BeginningYearBalanceAmt>
        <ContributionsAmt>393978</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>10985280</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>2930699</OtherExpendituresAmt>
        <EndYearBalanceAmt>82351106</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>67234621</BeginningYearBalanceAmt>
        <ContributionsAmt>316799</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>11263339</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>4912212</OtherExpendituresAmt>
        <EndYearBalanceAmt>73902547</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>55896829</BeginningYearBalanceAmt>
        <ContributionsAmt>529805</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>13834026</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>3026039</OtherExpendituresAmt>
        <EndYearBalanceAmt>67234621</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.93840</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.06080</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.00080</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>false</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>false</EndowmentsHeldRelatedOrgInd>
      <RelatedOrgListSchRInd>false</RelatedOrgListSchRInd>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>1963971</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>1364258</DepreciationAmt>
        <BookValueAmt>599713</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>663518</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>389743</DepreciationAmt>
        <BookValueAmt>273775</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>218022</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>195347</DepreciationAmt>
        <BookValueAmt>22675</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>896163</TotalBookValueLandBuildingsAmt>
      <OtherAssetsOrgGrp>
        <Desc>Accrued interest receivable</Desc>
        <BookValueAmt>181145</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>Beneficial interest in charitable trusts</Desc>
        <BookValueAmt>4531795</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>Inv in simple agreement for future eq.</Desc>
        <BookValueAmt>650000</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>Right-of-use asset - operating lease</Desc>
        <BookValueAmt>2047448</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>Security deposits</Desc>
        <BookValueAmt>21743</BookValueAmt>
      </OtherAssetsOrgGrp>
      <TotalBookValueOtherAssetsAmt>7432131</TotalBookValueOtherAssetsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>Operating lease payable</Desc>
        <Amt>2421896</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>2421896</TotalLiabilityAmt>
      <TotalRevEtcAuditedFinclStmtAmt>21463002</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>9511897</NetUnrealizedGainsInvstAmt>
      <OtherRevenueAmt>497853</OtherRevenueAmt>
      <RevenueNotReportedAmt>10009750</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>11453252</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>212106</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>212106</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>11665358</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>9696097</TotExpnsEtcAuditedFinclStmtAmt>
      <OtherExpensesIncludedAmt>94742</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>94742</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>9601355</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>212106</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>212106</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>9813461</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part IV, Line 2b: Explanation of escrow account liability</FormAndLineReferenceDesc>
        <ExplanationTxt>In 1996, The Eye-Bank for Sight Restoration, Inc. was made a beneficiary of the Mabel Hylton Trust for the express purpose of providing revenues generated by [its portion of] the trust to The Glaucoma Research Fund. The Eye-Bank receives an annual distribution from the trust and disburses funds to the designated researcher upon request. As custodian, The Eye-Bank is entitled to an administrative fee of 15% per annum.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part V, Line 4: Intended uses of the endowment fund.</FormAndLineReferenceDesc>
        <ExplanationTxt>The Eye-Bank has a policy of spending the investment income generated from the unrestricted board designated amounts in the portfolio fund. The Board of Directors of The Eye-Bank has adopted a policy to limit annual spending of investment earnings for current operations to 5% of the four-year average of the fair value of investments, excluding the two highest and two lowest performance quarters to reduce the effect of volatility on operational support. This is consistent with The Eye-Bank's objective to maintain the purchasing power of the portfolio fund assets held in perpetuity as well as to provide additional growth through investment return and new gifts.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part XI, Line 2d: Other revenue amounts included in F/S but not included on form 990</FormAndLineReferenceDesc>
        <ExplanationTxt>Change in value of beneficial interest $403111 Special event direct expense $94742</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part XII, Line 2d: Other expenses and losses per audited F/S</FormAndLineReferenceDesc>
        <ExplanationTxt>Special event expense $94742</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="IRS990ScheduleG" softwareId="23017517" softwareVersionNum="2023v5.1">
      <MailSolicitationsInd>X</MailSolicitationsInd>
      <EmailSolicitationsInd>X</EmailSolicitationsInd>
      <SolicitationOfNonGovtGrantsInd>X</SolicitationOfNonGovtGrantsInd>
      <SpecialFundraisingEventsInd>X</SpecialFundraisingEventsInd>
      <AgrmtProfFundraisingActyInd>false</AgrmtProfFundraisingActyInd>
      <FundraisingEventInformationGrp>
        <Event1Nm>Fall Event</Event1Nm>
        <GrossReceiptsEvent1Amt>102226</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>70589</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>31637</GrossRevenueEvent1Amt>
        <RentFacilityCostsEvent1Amt>11842</RentFacilityCostsEvent1Amt>
        <FoodAndBeverageEvent1Amt>30041</FoodAndBeverageEvent1Amt>
        <EntertainmentEvent1Amt>6000</EntertainmentEvent1Amt>
        <OtherDirectExpensesEvent1Amt>4245</OtherDirectExpensesEvent1Amt>
        <Event2Nm>Spring Benefit</Event2Nm>
        <GrossReceiptsEvent2Amt>87895</GrossReceiptsEvent2Amt>
        <CharitableContriEvent2Amt>48097</CharitableContriEvent2Amt>
        <GrossRevenueEvent2Amt>39798</GrossRevenueEvent2Amt>
        <RentFacilityCostsEvent2Amt>13716</RentFacilityCostsEvent2Amt>
        <FoodAndBeverageEvent2Amt>13715</FoodAndBeverageEvent2Amt>
        <EntertainmentEvent2Amt>4980</EntertainmentEvent2Amt>
        <OtherDirectExpensesEvent2Amt>1165</OtherDirectExpensesEvent2Amt>
        <OtherEventsTotalCnt>1</OtherEventsTotalCnt>
        <GrossReceiptsOtherEventsAmt>16583</GrossReceiptsOtherEventsAmt>
        <CharitableContriOtherEventsAmt>11875</CharitableContriOtherEventsAmt>
        <GrossRevenueOtherEventsAmt>4708</GrossRevenueOtherEventsAmt>
        <RentFcltyCostsOtherEventsAmt>5253</RentFcltyCostsOtherEventsAmt>
        <EntertainmentOtherEventsAmt>973</EntertainmentOtherEventsAmt>
        <OthDirectExpnssOtherEventsAmt>2812</OthDirectExpnssOtherEventsAmt>
        <GrossReceiptsTotalAmt>206704</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>130561</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>76143</GrossRevenueTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>30811</RentFcltyCostsTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>43756</FoodAndBeverageTotalEventsAmt>
        <EntertainmentTotalEventsAmt>11953</EntertainmentTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>8222</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>94742</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>-18599</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="IRS990ScheduleI" softwareId="23017517" softwareVersionNum="2023v5.1">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <Total501c3OrgCnt>0</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Cash</GrantTypeTxt>
        <RecipientCnt>3</RecipientCnt>
        <CashGrantAmt>16000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Grantmaker's Description of How Grants are Used</FormAndLineReferenceDesc>
        <ExplanationTxt>The candidate application process for Eye-Bank for Sight Restoration grants asserts that monies, if awarded, are intended for use in the United States. Required subsequent reporting from award recipients confirms that the award monies were used as intended.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="IRS990ScheduleJ" softwareId="23017517" softwareVersionNum="2023v5.1">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Dana Arifi</PersonNm>
        <TitleTxt>Dir Fin &amp; Admin</TitleTxt>
        <BaseCompensationFilingOrgAmt>140850</BaseCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>14085</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>15939</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>170874</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Edwin Roberts</PersonNm>
        <TitleTxt>Associate Director</TitleTxt>
        <BaseCompensationFilingOrgAmt>177796</BaseCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>17780</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>38546</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>234122</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Hortense Kendall</PersonNm>
        <TitleTxt>Laboratory Manager</TitleTxt>
        <BaseCompensationFilingOrgAmt>144194</BaseCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>14419</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>36702</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>195315</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Karen Bardavid</PersonNm>
        <TitleTxt>Dir of Development</TitleTxt>
        <BaseCompensationFilingOrgAmt>165448</BaseCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>16545</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>38521</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>220514</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Noel Mick Moschetta</PersonNm>
        <TitleTxt>Dir Communications</TitleTxt>
        <BaseCompensationFilingOrgAmt>159115</BaseCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>15912</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>16052</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>191079</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Patricia Dahl</PersonNm>
        <TitleTxt>CEO/Exec. Dir.</TitleTxt>
        <BaseCompensationFilingOrgAmt>311000</BaseCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>31200</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>16345</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>358545</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleM documentId="IRS990ScheduleM" softwareId="23017517" softwareVersionNum="2023v5.1">
      <SecuritiesPubliclyTradedGrp>
        <ContributionCnt>4</ContributionCnt>
        <NoncashContributionsRptF990Amt>15440</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>FMV</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <OtherNonCashContriTableGrp>
        <Desc>Auction assets</Desc>
        <ContributionCnt>68</ContributionCnt>
        <NoncashContributionsRptF990Amt>28910</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>FMV</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <AnyPropertyThatMustBeHeldInd>false</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>false</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>false</ThirdPartiesUsedInd>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="IRS990ScheduleO" softwareId="23017517" softwareVersionNum="2023v5.1">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER PROGRAM SERVICES 4: The Eye-Banks Ocular Tissue Research Program supplies donor eye tissue to medical scientists researching cures and treatment of eye diseases such as cataracts, glaucoma and diseases of the retina. The Eye-Bank also provides adult human Retina Pigment Epithelial (ah-RPE) cells to a growing number of researchers across the country who are conducting studies on the potential for transplanting RPE cells in the future. The Eye-Bank distributed 121% more donor tissue to researchers in 2023 (190 tissues) over 2022 (86 tissues). This significant increase is due in part to The Eye-Banks addition of a Research and Relationship Development Manager position as well as our hosting a reception at the 2023 meeting of ARVO (Association for Research in Vision and Ophthalmology) which enabled us to meet in-person with researchers currently using our donor tissue and cultivate new opportunities for our Research Program to collaborate. OTHER PROGRAM SERVICES 5: The Young Ambassador Program invites cornea transplant recipients ages four to 17 to express themselves creatively through art and poetry and selected efforts are featured in The Eye-Banks annual Thanksgiving Card. The program also awards two annual $3,000 scholarships to qualifying student applicants pursuing higher education -- one for a successful public education project and one for a STEM research paper describing a way to increase eye donation. OTHER PROGRAM SERVICES 6: The Eye-Banks Marketing Program continued to inform the public about the importance of eye donation and enrolling in the Donate Life Registry through its highly-successful multi-media advertising campaign that reaches a New York metropolitan audience via, television, radio and newspapers as well as social media platforms and email marketing. Both media and digital marketing placement includes Spanish language outlets. The 2023 ad campaign Be a Hero at the DMV reinforced the opportunity for New Yorkers to enroll in the Donate Life Registry while conducting transactions at the DMV.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, Line 11b</FormAndLineReferenceDesc>
        <ExplanationTxt>The Finance Committee reviewed the 2023 Form 990 in detail. With the Committee's approval, it was presented to the full Board at the October meeting and all questions and comments were resolved prior to filing.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, Line 12c</FormAndLineReferenceDesc>
        <ExplanationTxt>A Director or Officer shall disclose a conflict of interest: (a) prior to voting on or otherwise discharging his duties with respect to any matter involving the conflict which comes before the Board or any committee; (b) prior to entering into any contract or transaction involving the conflict; (c) as soon as possible after the Director or Officer learns of the conflict; and (d) on the annual conflict of interest disclosure form.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, Line 15a</FormAndLineReferenceDesc>
        <ExplanationTxt>The Executive Committee functions as the Compensation Committee. The Committee annually reviews the past year's goals and outcomes as well as the goals for the coming year of the Executive Director and then approves the salary of the Executive Director for the new fiscal year. Compensation decisions are substantiated by contemporaneous emails.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section C, Line 19</FormAndLineReferenceDesc>
        <ExplanationTxt>The Eye-Bank makes its governing documents available to the public as mandated by federal disclosure requirements. The Federal Form 990 is also available on Guidestar.org.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part XI, Line 9</FormAndLineReferenceDesc>
        <ExplanationTxt>Change in value of beneficial interest in charitable trusts = $403111</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>